Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.
Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.
Targeted ultrasound therapy offers a less invasive prostate cancer treatment designed to minimize disruption to daily life.
Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...
Morning Overview on MSN
New prostate cancer immunotherapy slashes biomarkers by up to 99%
An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...
The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...
CURE highlights prostate cancer advancements from Day One of the 2026 ASCO Genitourinary Cancers Symposium.
Docetaxel added to androgen deprivation therapy (ADT) was the most cost-effective first-line regimen for patients with ...
The average age of men who get diagnosed is 67.
However, men with higher PSA levels did show modest improvements in survival, suggesting that hormone therapy might be worthwhile for them. PSA (prostate-specific antigen) is produced by the prostate ...
Three years ago, Maurice Blake was diagnosed with prostate cancer. "I didn't have any of the traditional symptoms, apart from ...
"This technology gives us a powerful tool to detect prostate cancer earlier and more precisely,” said Dr. James Howard.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results